HIGHLIGHTS
- who: Sarah Rouhana et al. from the Research Laboratory in Physiology and Physiopathology, University Saint Joseph, Beyrouth, Lebanon have published the article: Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning, in the Journal: Pharmaceuticals 2022, 31 of 10/Dec/2021
- what: The experiment was performed as described . In this study, the subjective symptoms of stiffness, weakness, and pain, as well as clinical and electrical myotonia, were evaluated.
- future: Future studies with ranolazine may consider these benefits due to the recent success of non-specific . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.